Willow Biosciences Inc. announced that the Board of Directors has appointed Dr. Peter Seufer-Wasserthal as Interim President and Chief Executive Officer, effective July 17, 2022, in connection with Trevor Peters' retirement as President and CEO. Mr. Peters will continue to be a Director of the Company. In addition to the above mentioned changes, Ms. Barbara Munroe, a Director of the Company, has been appointed as Lead Independent Director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 CAD | -4.55% | 0.00% | +5.00% |
1st Jan change | Capi. | |
---|---|---|
+5.00% | 9.77M | |
+0.78% | 93.19B | |
0.00% | 39.62B | |
-10.35% | 33.78B | |
+64.64% | 26.82B | |
-16.15% | 15.35B | |
-6.98% | 13.13B | |
-11.77% | 11.6B | |
-49.19% | 10.26B | |
+8.09% | 9.43B |
- Stock Market
- Equities
- WLLW Stock
- News Willow Biosciences Inc.
- Willow Biosciences Inc. Appoints Dr. Peter Seufer-Wasserthal as Chief Executive Officer